HBC February 2016 News Bulletin

Wednesday, February 24, 2016


HBC Science Talks 2016 – Great Success

This year’s HBC Science Talks meeting held on February 19, 2016 was a great success and was attended by over seventy people.  The four guest speakers, Josie Chandler, Mario Rivera, Joanna Slusky, and Jeff Staudinger, all gave very informative and interesting lectures.  We thank them for sharing their time and expertise with their remarkable presentations.  

Thirty four posters covering six thematic research areas as well as the “enabling technologies” area were presented during the poster session immediately following the speakers session.  We are grateful to all who participated in sharing their research.  All speakers’ and posters’ abstracts, as well as some pictures of the event can be found on the HBC website at http://hbc.ku.edu/science-talks.

  

 

Understanding your NIH grant number

While attending the 2015 NIH Regional Seminar held in San Diego last October, participants received informational material.  One such informational flyer provided a short and effective description of the meaning behind NIH grant numbering.  That information is provided below as a handy informational tidbit:


Grant Number:


 



Grant Submission Important Deadlines

April 12, 2017
NIH standard deadline for Conference Grants and Conference Cooperative Agreements (R13, U13) – new renewal, resubmission, revision.

No Date Yet
American Heart Association (AHA) DoD Breast Cancer Program Fiscal year 2017 - pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.

Recent Awards

David Johnson, Interim Director, COBRE CBID Computational Chemical Biology Core Facility, was awarded $2,903 by Sanofi-Aventis Recherche & Développement for his project entitled: “Prediction of druggable pockets unique to cancer-associated mutations.”

Scott Lovell, Director, COBRE PSF Protein Structure Core Laboratory, was awarded $12,120 by the Fox Chase Cancer Center for his project entitled: “Identifying stabilizers of p53 using pocket complementarity.”

David Volkin, Ronald T. Borchardt Distinguished Professor, Department of Pharmaceutical Chemistry, was awarded $550,000 by Vaxxas for his project entitled: “Measles and Rubella Vaccine Formulation for Stability in Dried State.”

Yong Zeng, Assistant Professor, Department of Chemistry, was awarded $410,564 by the National Institutes of Health for his project entitled: “Microfluidic Integrative Circulating miRNA Profiling for Cancer Diagnosis”.  He was also awarded $25,000 by K-INBRE as mentor of Hongmei Cao’s K-INBRE Postdoctoral Award for his project entitled: “Microfluidic Integrative Circulating miRNA Profiling for Cancer Diagnosis.”

One of 34 U.S. public institutions in the prestigious Association of American Universities
Nearly $290 million in financial aid annually
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
23rd nationwide for service to veterans —"Best for Vets," Military Times
KU Today